Market Research Report
Global Ventricular Assist Devices Market Analysis (2017-2023)
|Published by||KBV Research||Product code||639326|
|Published||Content info||198 Pages
Delivery time: 1-2 business days
|Global Ventricular Assist Devices Market Analysis (2017-2023)|
|Published:||Content info: 198 Pages||
This publication has been discontinued on August 13, 2018.
Ventricular Assist Devices Market is estimated to reach $1.8 billion by 2023, growing at a CAGR of 12% during the forecast period.
Ventricular assist devices are implantable mechanical pumps used in controlling the blood flow from ventricles of heart to the rest of body. These devices replicate the functioning of ventricles and are implanted to the end of heart and to helps the flow of blood from ventricles to the body. These flow pumps could be either pulsatile or continuous, where the continuous flow pump circulates blood continuously, while the pulsatile pump mimics the natural heart pulse.
The major factors that drive the growth of the global ventricular assist devices market are growing patients' pool with heart failures and shortage of heart donors. Additionally, the technically advanced VAD (DuraHeart, HeartMate III) are devices that add to the market growth. Nevertheless, these devices are costly, and also have risks such as blood clots and bleeding, which would limit the market growth significantly.
Based on product, the market report segments the market into Left Ventricular Assist Devices (LVADs), Right Ventricular Assist Devices (RVADs), and Biventricular Assist Devices (BIVADs). Based on Application, the Global Ventricular Assist Devices market segments the market into Bridge-to-transplant (BTT) Therapy, Destination Therapy, Bridge-to-recovery (BTR) Therapy, and Bridge-to-candidacy (BTC) Therapy. Based on Design, the market report segments the market into Transcutaneous Ventricular Assist Devices and Implantable Ventricular Assist Devices. The report also covers geographical segmentation of Ventricular Assist Devices market. The geographies included in the report are North America, Europe, Asia-Pacific, and Latin America, Middle East & Africa. For the better analysis, the geographies are segmented into countries.
The market research report covers the analysis of key stake holders of the Global Ventricular Assist Devices Market. Key companies profiled in the report include Berlin Heart GmbH, Cardiac Assist, Inc., HeartWare International, Inc., Jarvik Heart, Inc., Reliant Heart, Inc., St. Jude Medical, LLC, Sun Medical Technology Research Corp., Syncardia System, Inc., Thoratec Corporation, and Abiomed.